News + Filings Transactions
All All (ex-4s) 10-K 10-Q 8-K 3,4,5 Proxy Prospectus Other
|
Sorensen Mel
|
Create: Alert |
All | News | Filings
Date Filed | Type | Description |
03/14/2023 |
4
| Sorensen Mel (President and CEO) has filed a Form 4 on Galera Therapeutics, Inc.
Txns:
| Bought 100,000 shares
@ $1.6812, valued at
$168.1k
|
|
02/28/2023 |
4
| Sorensen Mel (President and CEO) has filed a Form 4 on Galera Therapeutics, Inc.
Txns:
| Granted 440,000 options to buy
@ $1.78, valued at
$783.2k
|
|
03/02/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
03/30/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
01/28/2021 |
4
| Sorensen Mel (President and CEO) has filed a Form 4 on Galera Therapeutics, Inc.
Txns:
| Granted 190,000 options to buy
@ $11.99, valued at
$2.3M
|
|
02/04/2020 |
4
| Sorensen Mel (President and CEO) has filed a Form 4 on Galera Therapeutics, Inc.
Txns:
| Granted 186,087 options to buy
@ $14.84, valued at
$2.8M
|
|
11/06/2019 |
3
| Sorensen Mel (President and CEO) has filed a Form 3 on Galera Therapeutics, Inc. |
|
|